BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Akums Drugs & Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544222
ISIN Demat
INE09XN01023
Book Value (Rs)
154.2895525
NSE Symbol
AKUMS
Divident Yield %
0.44
Market Cap
(Rs In Cr.)
10,427
P/E (TTM)
89.52
EPS (TTM)
7.4
Face Value
(Rs)
2
Back
Akums Drugs & Pharmaceuticals consolidated net profit rises 1.75% in the December 2025 quarter
14-Feb-26   Hrs IST

Net profit of Akums Drugs & Pharmaceuticals rose 1.75% to Rs 66.32 crore in the quarter ended December 2025 as against Rs 65.18 crore during the previous quarter ended December 2024. Sales rose 14.76% to Rs 1159.59 crore in the quarter ended December 2025 as against Rs 1010.41 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales1159.591010.41 15
OPM %12.6612.01 -
PBDT157.45130.79 20
PBT117.8086.27 37
NP66.3265.18 2

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)